免费 发表于 2025-3-26 23:36:48
Jianfeng Xu,Duoqian Miao,Li Zhang,Yiyu Yaorence be given to assist devices over total artificial hearts (TAHs). There is no scientific background for this and the right ventricle is the least difficult to make. In December 1982, Dr. Barney Clark received the first TAH meant for permanent use. Later, the Food and Drug Administration (FDA) deBenign 发表于 2025-3-27 01:33:07
Piotr Wasilewski,Janusz Kacprzyk,Sławomir Zadrożny goals for this system throughout its 17-year development cycle. The system is designed for the ultimate use as an alternative to transplant and thus is configured to provide the patient freedom from external control consoles. Patients are to be discharged from the hospital to an active social life.neoplasm 发表于 2025-3-27 08:53:48
Chengzhi Shi,Taihua Xu,Fuhao Cheng,Xibei Yang,Jianjun Chenolymer materials have been developed to prevent thrombus formation, they have problems in long-term applications. While the natural antithrombogenicity of endothelial cells is reliable, development of the cell lining requires long periods after implantation. To overcome this problem, we developed a商业上 发表于 2025-3-27 10:27:24
http://reply.papertrans.cn/84/8319/831896/831896_34.pngPolydipsia 发表于 2025-3-27 15:29:10
compatibility in in vitro and ex vivo experiments. The present study was carried out to evaluate the possible application of HEMA-st coating to a small vessel substitute. As a pilot study, HEMA-st-coated grafts, 6-mm in internal diameter and 7-cm-long, were evaluated as abdominal aortic replacement约会 发表于 2025-3-27 18:33:56
Azimkhon Ostonov,Mikhail Moshkovro and in vivo studies. The system comprises a blood pump system with diaphragm-type ellipsoidal ventricles, an energy converter system consisting of a regenerative pumpbrushless DC motor assembly, and an electronics system with transcutaneous energy transfer (TET) and optical telemetry (TOT) systemIge326 发表于 2025-3-27 23:34:00
http://reply.papertrans.cn/84/8319/831896/831896_37.png摇摆 发表于 2025-3-28 02:16:33
Stefania Boffa,Davide Ciuccient revisions of the design of our miniature intraventricular axial flow left ventricular assist device (LVAD) were aimed particularly toward addressing these concerns. To improve hemocompatibility, a new impeller (13.5-mm diameter) has been designed according to the following criteria: (1) gradualDECRY 发表于 2025-3-28 08:53:40
http://reply.papertrans.cn/84/8319/831896/831896_39.png袋鼠 发表于 2025-3-28 12:07:50
Prosenjit Howlader,Churn-Jung Liauplanted it in 60- to 70-kg sheep in tether-free operations. The moving-actuator mechanism in this TAH was adapted to decrease the distance among the four inlet and outlet ports for fitting to human remnants. This TAH has no external compliance chamber, and the left-to-right balance of cardiac output